Novavax
NVAX
161 hedge funds and large institutions have $295M invested in Novavax in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 46 reducing their positions, and 17 closing their positions.
35% more capital invested
Capital invested by funds: $218M → $295M (+$76.9M)
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
14% more call options, than puts
Call options by funds: $3.11M | Put options by funds: $2.72M
3% more funds holding
Funds holding: 156 → 161 (+5)
0.08% less ownership
Funds ownership: 2.13% → 2.05% (-0.08%)
17% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 46
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$6.64M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$4.21M |
| 3 |
JP Morgan Chase
New York
|
+$2.36M |
| 4 |
BlackRock
New York
|
+$1.93M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$8.35M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$4.44M |
| 3 |
Morgan Stanley
New York
|
-$3.93M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.89M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$1.68M |
NVAX Hedge Fund Activity: Q3 2018 in Review
161 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2018, worth a combined $295M — up 35% from $218M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new NVAX positions and 17 closed out — a net gain of 5 holders — while 38 added to existing stakes and 46 trimmed.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $6.64M. The largest seller was State Street, cutting an estimated $8.35M.
- 161 institutional investors held Novavax (NVAX) as of Q3 2018, up from 156 in Q2 2018.
- Funds reported $295M of Novavax stock for Q3 2018, up 35% quarter-over-quarter.
- 22 funds opened new Novavax positions in Q3 2018 and 17 closed out, a net change of +5 holders.
- The largest Novavax buyer in Q3 2018 was Baker Bros. Advisors, an estimated $6.64M added.
- The largest Novavax seller in Q3 2018 was State Street, an estimated $8.35M sold.
Based on aggregated 13F filings for Q3 2018.